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A AB BS ST TR RA AC CT T
O Ob bj je ec ct ti iv ve e: : To evaluate our learning-curve experience
with laparoscopic management of endometrial carcinoma.
M Me et th ho od ds s: : Retrospective review of our first 125 patients
with endometrial cancer who were managed laparoscopi-
cally.  The patient population was reviewed in a chrono-
logical manner, noting patient demographics, operative
procedure and times, estimated blood loss, hospital stay,
complications, and pathology.
R Re es su ul lt ts s: : Overall, the mean age was 68.6 years (range 29-
89), the mean weight was 160 pounds (range 97-328), and
the mean Quetelet index was 27.8 (range 17.8-56.4).
Metastatic disease was discovered in 28.8% (17/59) of
patients with grade 2 or 3 lesions.  There was no statisti-
cally significant variation in any of these parameters
throughout the study.  Operative times for staging without
lymphadenectomy decreased significantly from a mean of
163 minutes to 99 minutes (p<.001).  Operative times for
staging with lymphadenectomy decreased from a mean of
196 minutes to 128 minutes (p<0.02).  Hospital stay
decreased from a mean of 3.2 days in the first quarter of
our study to 1.8 days (p<.0001).  The overall average com-
plication rate of 4% (two enterotomies, two cystotomies,
and a transected ureter) did not vary.  However, the rate of
conversion to laparotomy dropped significantly from 8%
(2/25) to 0% (0/100).
C Co on nc cl lu us si io on ns s: : We found that operative times and hospi-
tal stays for laparoscopic staging of endometrial cancer con-
tinued to drop after 125 cases.  While the ability to detect
metastatic disease and the rate of major complications
appear unrelated to length of the operator experience, the
conversion rate to laparotomy decreases with operator
experience.  Learning-curve parameters must be recog-
nized by physicians, patients, and researchers for a host of
reasons.
I IN NT TR RO OD DU UC CT TI IO ON N
There are approximately 39,000 new cases of endometrial
cancer diagnosed in the United States annually.  Abdominal
hysterectomy and adnexectomy have been the standard of
care for many years.  Lymphadenectomy has been routine
for many of these patients since 1988, when the Federation
of Gynecology and Obstetrics (FIGO) changed the staging
of endometrial cancer from a clinical to a surgical
approach.1 The new staging protocols required (a) assess-
ment of the intraperitoneal cavity; (b) cytologic sampling;
(c) adnexectomy; (d) lymphadenectomy; and (e) hysterec-
tomy.
Recently, there have been many advancements in laparo-
scopic surgical techniques and instrumentation that have
facilitated the transition of traditionally open surgical cases
to operative laparoscopic operations.  Laparoscopically
assisted vaginal hysterectomy and complete hysterectomy
along with laparoscopic pelvic and para-aortic lym-
phadenectomy have allowed operative laparoscopists to
surgically stage patients with endometrial cancer.2-4
Not surprisingly, the use of laparoscopy in the surgical
management of endometrial and other gynecologic malig-
nancies is controversial.  Proponents of operative
laparoscopy espouse the adequacy, safety, and reduced
recovery time.  Skeptics of laparoscopy point out the prob-
lems of lymphadenectomy in obese patients and of the lack
of randomized prospective studies.  Traditionally, compar-
ative randomized clinical trials have been the scientific gold
standard to test new management approaches in oncology.
Pioneers in laparoscopic surgery have been encouraged to
institute randomized studies.5,6 Indeed, the Gynecologic
Oncology Group (GOG) has initiated a randomized
prospective study evaluating operative laparoscopic staging
of patients with endometrial carcinoma.
Few studies to date have addressed at what point an oper-
ative laparoscopic surgeon has become accomplished
enough to compare results of his laparoscopic technique to
those of laparotomy.  The laparoscopic learning-curve is
often referred to but infrequently defined.  While scant, the
most data exist on general surgical procedures such as
JSLS -96-114  3/29/06  8:10 PM  Page 146 JSLS(1997)1:45-49
cholecystectomy and appendectomy.  Publication of these
data has been generated largely to address the issue of
increased frequency of operative complications noted in
neophytes.  Even fewer reports exist on gynecologic
surgery, and no data are currently available for gynecolog-
ic oncology procedures.
We review retrospectively our experience with our first 125
patients with endometrial cancer who were managed
laparoscopically.  Our purpose was to better define the
learning-curve parameters such as operative time, blood
loss, complications, hospital stay, and our ability to detect
metastatic disease by this means. 
M MA AT TE ER RI IA AL LS S   A AN ND D   M ME ET TH HO OD DS S
A retrospective review of the first 125 patients with laparo-
scopically managed preoperative clinical stage I endometri-
al cancer was carried out from May, 1991, through May,
1996.  The charts were reviewed and the following data
extracted:  age, weight, Quetelet index, hospital stay, EBL,
operative time, pathology, and operative complications.
The results were evaluated by means with associated
ranges.  To evaluate the learning-curve, the data were eval-
uated over time for the 61 months of the study.  The data
were then subjected to statistical analysis using the
Kruskall-Wallis Nonparametric ANOVA tests, Dunn’s
Multiple Comparison Test, and linear regression, with P val-
ues <0.05 being considered significant.
All operative procedures were performed by one or both of
two authors (JMC and EAS).  There was no selection bias
such as age, weight, or previous surgeries.  The operative
procedure was done systematically.  Initial evaluation of
the peritoneal cavity was followed by the collection of peri-
toneal cytology.  In those patients with preoperative grade
1 lesions, laparoscopic hysterectomy (either assisted or
complete) was carried out and the uterus sent to patholo-
gy for frozen-section determination of both grade and
depth of myometrial invasion.  If the lesion was upgraded,
or if the depth of invasion exceeded one-half the myome-
trial thickness, or if the tumor covered a majority of the
anterior and posterior walls of the uterus, laparoscopic lym-
phadenectomy was performed.  In patients with preopera-
tive grade 2 or 3 lesions, the lymphadenectomy was per-
formed prior to the hysterectomy.  Lymph node sampling
included pelvic nodes and/or para-aortic nodes.4  Operative
times were obtained from the anesthesia record and EBL
from the surgeon’s estimation.
R RE ES SU UL LT TS S
Overall, the patients had a mean age of 68.6 years (range
29-89), with a mean weight of 160.4 pounds (range 97-328).
The mean Quetelet index is 27.8 (range 17.8-56.4).  There
was no statistical difference in patient age, weight, or body-
mass index throughout the study.
Of the 125 patients, 65 underwent hysterectomy and
adnexectomy, and 60 underwent hysterectomy, adnexecto-
my, and pelvic and/or para-aortic lymphadenectomy.
Obesity precluded the para-aortic lymphadenectomy in
three patients (Quetelet index = 47.2, 47.3, and 56.4).  
Overall, there were 66 grade 1, 34 grade 2, and 25 grade 3
malignancies.  No metastatic disease was discovered in
patients with well-differentiated tumors.  Metastatic disease
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was discovered in 18% (6/34) of patients with grade 2
lesions and 44% (11/25) of patients with grade 3 lesions.
There was no statistical difference (p=0.29) throughout the
study in our ability to surgically detect metastatic disease
( (F Fi ig gu ur re e   1 1) ).
Operative times were noted separately between those
patients undergoing combined hysterectomy and lym-
phadenectomy and those undergoing hysterectomy without
lymphadenectomy.  Operative times for staging without
lymphadenectomy decreased from a mean of 163 minutes
in the first quarter of our experience to 99 minutes in the
final quarter.  This decrease was highly significant statisti-
cally when plotted on the linear regression (p<0.0001)
F Fi ig gu ur re e   2 2. . Similarly, the operative time for combined hys-
terectomy and lymphadenectomy decreased from a mean
of 196 minutes in the first 25 patients to 128 minutes in the
last 25.  This decrease was also statistically significant when
plotted on the linear regression (p<0.0002) ( (F Fi ig gu ur re e   3 3) ).
The mean estimated blood loss was 240 cc with a range of
50-1000.  When the EBL of all patients was plotted on a lin-
ear regression curve, the drop was statistically significant
(p=0.03) ( (F Fi ig gu ur re e   4 4) ).
Length of hospital stay steadily decreased throughout the
study period.  The mean hospital stay for the initial 25
patients was 3.2 days (range 1-6 days) and decreased to a
mean of 1.8 days (range 0-3) in the last 25 patients.  The
linear regression analysis of the hospital stay relative to
operator experience was quite significant statistically
(p<0.0001) ( (F Fi ig gu ur re e   5 5) ).
There were five significant operative complications:  two
cystotomies, one colotomy, one enterotomy, and one
ureteral injury.  All but the latter were recognized intraop-
eratively.  Two injuries occurred in the first 25 patients, one
in the third group of 25, and two in the fourth group of 25
patients in our study.  The first two injuries required laparo-
tomy for repair.  The last three injuries (an enterotomy dur-
ing adhesiolysis, a transverse colotomy from primary trocar
insertion, and a cystotomy from a suprapubic trocar) were
all repaired laparoscopically.  There was no appreciable
difference in the rate of major complications throughout the
study period.  However, the laparotomy rate dropped
impressively, from 8% (2/25) in the first 25 patients to 0%
(0/100) in the final 100 patients of the study.
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D DI IS SC CU US SS SI IO ON N
Very little is known about the operative laparoscopic learn-
ing-curve in any surgical specialty.  Early evaluation of
laparoscopic cholecystectomy has demonstrated that com-
petency (defined by one’s ability to perform the intended
procedure with complication rates similar to those of tradi-
tional surgery) can be attained, but that a long learning
curve, requiring as many as 300 cases, may be needed to
acquire adequate experience.7-11 Similarly, the learning
curve appears to be long for gynecologic procedures.
Weber et al demonstrated a continued drop in the time
required to perform ovarian cystectomy in their experience
of more than four years.12 Likewise, Harkki-Siren et al
demonstrated a continuous drop in the operative time
required to perform their first 100 laparoscopic hysterec-
tomies.13 No data exist on the learning experience in gyne-
cologic malignancies.
Data on the learning experience are important for a num-
ber of reasons.  Individual physicians need to be aware of
the number of procedures and the length of time required
to master a new laparoscopic technique.  Patients should
be cognizant of this phenomenon and aware of their sur-
geon’s experience.  Interpretation of current literature must
take into account the learning hurdle.  Randomized trials,
designed to make fair comparisons, must take the learning
curve into consideration when comparing laparoscopy to
laparotomy.  When can an accomplished laparotomist com-
pare his laparoscopy and laparotomy skills?  Our data show
that statistically significant reductions in operative time
occur and continue to occur after 125 patients and five
years of time.  The current GOG protocol comparing endo-
scopic and open surgical staging requires that participating
oncologists (experienced laparotomists) have taken a
laparoscopy course and have performed two adequate
laparoscopic pelvic and para-aortic lymphadenectomies.
Our data demonstrated the reduction in length of hospital
stay was highly significant with regard to operator experi-
ence ( (F Fi ig gu ur re e   5 5) ).  When the data are examined in groups
of 25 patients, the length of stay appears to have leveled off
after 75 patients to around 1.75 days ( (F Fi ig gu ur re e    6 6) ).  We
believe this hospital stay learning-curve reflects the learning
of surgeons as well as hospital nurses.  Surgeons have
improved their skills, and both surgeons and nurses have
learned that patients can go home earlier than before.  We
routinely educate our patients preoperatively concerning
expectations about a short hospital stay and recovery time.
It should be noted that hospital stays for laparotomy have
decreased in most institutions over this time as well.
However, we do not believe that hospital stays for staging
of patients via laparotomy will approach the 1.75 day range.  
The detection of metastatic disease appears to be indepen-
dent of operator experience.  This would suggest that the
procedure itself is adequate from the beginning.  Our over-
all rate of metastatic disease of 29% (17/59) for grade 2 and
3 lesions is comparable to that of surgical staging operations
performed via traditional laparotomy.14-16
Our rate of major complications is comparable to that of
recently reported studies in surgical staging via laparotomy.
These reports indicate that thromboembolic events
occurred in 1.2-9.5%, transfusion rates of 6-10%, fistulas 0-
2%, myocardial infarction 0-5.7%, evisceration 0-1%, ureter-
al injury 0-1.2%, and mortality 0-0.7%.17-19  We had no
thromboembolic events, had a 2% transfusion rate, and two
of the major complications we encountered were small cys-
totomies.  This lack of association of complications with
operator experience has been demonstrated by other
authors.13
Since many patients with endometrial cancer are obese,
some physicians are concerned about their ability to per-
form laparoscopic surgery in the majority of patients who
have been evaluated preoperatively.  Kadar et al recently
published their experience with laparoscopic lym-
phadenectomy in ten patients weighing at least 180 pounds
(mean 212 pounds).20 Their ability to successfully accom-
plish retroperitoneal surgery was echoed by our own expe-
rience, in which we were able to stage 22 patients laparo-
scopically who weighed >180 pounds (mean 205.5).  Only
three patients had incomplete staging directly related to
obesity (Quetelet index 47.3, 47.2, and 56.4 respectively).
The well-known association of well-differentiated endome-
trial carcinomas and obesity works to the laparoscopist’s
advantage if lymphadenectomy is avoided in superficially
invasive grade 1 lesions.
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Our results should be interpreted with the knowledge that
our surgeons performed concomitantly more than 700 addi-
tional operative laparoscopic procedures for benign and
malignant disease during the study period.  These learning
curves reflect the experience of surgeons dedicated to
operative laparoscopy, and we believe the rate of operative
laparoscopic experience is one important parameter of any
individual learning curve.
Our results indicate that physicians trained in laparoscopic
lymphadenectomy can safely offer laparoscopic staging to
their patients.  As neophytes, their procedures probably will
be longer and their patients probably will remain hospital-
ized longer than those of their more experienced col-
leagues, but the adequacy and safety of their initial proce-
dures probably will equal those of experienced laparo-
scopists. Prospective randomized trials comparing
laparoscopy with laparotomy should not compare opera-
tive times, hospital stays, conversions to laparotomy, or
estimated blood loss unless the surgeons have adequate
laparoscopic experience.
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